Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
申请人:Pfizer Inc.
公开号:US05712303A1
公开(公告)日:1998-01-27
The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.